Viking Therapeutics (VKTX) October 25 weekly option implied volatility bid into quarter results

Go back to Viking Therapeutics (VKTX) October 25 weekly option implied volatility bid into quarter results

BTIG Reiterates Buy Rating on Viking Therapeutic (VKTX)

October 24, 2024 5:42 AM EDT

BTIG analyst Justin Zelin reiterated a Buy rating and $125.00 price target on Viking Therapeutic (NASDAQ: VKTX).

The analyst comments "Viking reported 3Q24 earnings with focus on the higher dose oral VK2735 data expected at Obesity Week in a poster presentation... More